Download the Free E-Book "What to Expect from Treatment"

Drug Law News

New Law Would Allow Supervised Injection Sites in Ireland

Posted on July 3, 2015 in Drug Law News

New Law Would Allow Supervised Injection Sites in IrelandNew legislation is being drafted that would introduce medically supervised injection sites for heroin abusers in Ireland. Although there are many potential benefits to the approach, there are understandable criticisms, and the debate cuts to the heart of the larger issue regarding the role of harm reduction in reducing the drug problem around the world. The legislation was proposed once before and was shot down almost immediately, but the new draft of the legislation might have the power to change minds. The approach has already been instituted in Canada, and it’s likely to become more popular in the U.S. and around the world in response to rising heroin abuse. 

Read more about New Law Would Allow Supervised Injection Sites in Ireland

Silk Road Founder Ross Ulbricht, aka Dread Pirate Roberts, Gets Life in Prison

Posted on July 1, 2015 in Drug Law News

Silk Road Founder Ross Ulbricht, aka Dread Pirate Roberts, Gets Life in PrisonRoss Ulbricht, the founder and administrator of an illegal online drug marketplace called the Silk Road, has been sentenced to life in prison without the possibility of parole. 

Read more about Silk Road Founder Ross Ulbricht, aka Dread Pirate Roberts, Gets Life in Prison

Massachusetts State Bill Stirs Opioid Addiction Treatment Debate

Posted on January 6, 2015 in Drug Law News

Massachusetts State Bill Stirs Opioid Addiction Treatment DebateAll across the U.S., communities are facing an epidemic of opioid addiction and all the negative consequences associated with it. What began with prescription painkillers has morphed into a heroin epidemic. The need for treatment to help the thousands of addicts is great, but experts still debate the best way in which to reach and care for everyone. A bill in the Massachusetts Legislature is stirring that debate, specifically over the effectiveness of inpatient treatment and who should pay for it.

Read more about Massachusetts State Bill Stirs Opioid Addiction Treatment Debate

New Massachusetts Substance Abuse Law Emphasizes Treatment

Posted on October 5, 2014 in Drug Law News

New Massachusetts Substance Abuse Law Emphasizes TreatmentA new bill signed into state law by Gov. Deval Patrick of Massachusetts has garnered national attention. The bill is designed to fight substance abuse in the state, and it places a significant emphasis on treatment for people living with substance use disorders.

The legislation requires insurance companies to cover a number of services that have not been universally available, including up to 14 days of inpatient treatment for those with substance use disorders. The bill received bipartisan support in the Massachusetts legislature.

Read more about New Massachusetts Substance Abuse Law Emphasizes Treatment

New York Passes Series of Drug-Abuse Related Bills

Posted on September 3, 2014 in Drug Law News

New York Passes Series of Drug-Abuse Related BillsOn June 18, 2014, the New York state legislature passed a series of bills that will affect drug abuse prevention, drug abuse treatment and drug distribution penalties throughout the state.

New York Governor Andrew M. Cuomo and the state legislature had made it clear that addressing the state’s opioid abuse problem was a priority before the end of the legislative session on June 19th. Lawmakers hope that the new measures will improve access to treatment for many people with opioid addictions and also provide more tools for law enforcement when it comes to disrupting the illegal sale of prescription and street opioids. 

Read more about New York Passes Series of Drug-Abuse Related Bills

FDA Rejects Approval of Powerful Moxduo

Posted on May 25, 2014 in Drug Law News

FDA Rejects Approval of Powerful MoxduoA key government panel has voted against approval of a powerful opioid prescription painkiller called Moxduo that is said to offer faster relief with fewer side effects than other painkillers on the market.

In April, the Anesthetic and Analgesic Drug Products Advisory Committee for the U.S. Food and Drug Administration (FDA) rejected the application for Moxduo. Moxduo is a strong opioid narcotic painkilling drug manufactured by the pharmaceutical company QRxPharma. The drug combines morphine and oxycodone, two opioid painkillers that are currently manufactured separately under a variety of names. 

Read more about FDA Rejects Approval of Powerful Moxduo

States’ Supply Chains Blamed for Increased Marijuana Potency

Posted on May 14, 2014 in Drug Law News

States’ Supply Chains Blamed for Increased Marijuana PotencyMedical marijuana is the common term for marijuana issued via prescription by a licensed physician. Although federal statutes prohibit the use of marijuana in this (or any other) context, roughly a third of all U.S. states have laws that permit doctors to prescribe the drug. In a study published in March 2014 in the International Journal of Drug Policy, researchers from two U.S. institutions sought to determine if state-level laws permitting doctors to prescribe medical marijuana have contributed to a sharp increase in marijuana potency that has occurred over the last 20-plus years.

Read more about States’ Supply Chains Blamed for Increased Marijuana Potency

Billie Joe Armstrong Battles Addiction

Posted on July 14, 2013 in Drug Law News

In a tale too often told, another rock star has revealed that his stint in rehab was due to alcohol and prescription pill addiction.

Billie Joe Armstrong, who has enjoyed another round of success following his early 1990s success with punk rock group Green Day, recently revealed that he would use substances to such a degree that he would black out. He said that at times he would awaken in a strange place, unaware of how he got there.

Read more about Billie Joe Armstrong Battles Addiction

Will FDA Restrictions on Vicodin and Other Opioids Lower Addiction

Posted on July 6, 2013 in Drug Law News

Will FDA Restrictions on Vicodin and Other Opioids Lower AddictionToday, around 47 million Americans are taking pills made with Hydrocodone to manage some form of chronic pain. Known as opioids, these painkillers have become the focal point of a swirling debate. On one side are patients who are living with barely manageable chronic pain for whom the drugs are a godsend. On the other side are the families of those addicted to opioids, drug enforcement agencies and even the Center for Disease Control and Prevention (CDC).  According to the CDC, abuse of prescription opioids is an epidemic problem in this country.

Read more about Will FDA Restrictions on Vicodin and Other Opioids Lower Addiction

Policymakers Urge FDA to Do Its Part in Limiting Prescriptions for Vicodin

Posted on June 29, 2013 in Drug Law News

Limiting Prescriptions for VicodinIn a letter to the Food and Drug Administration (FDA), Senator Joe Manchin of West Virginia demanded that the organization stand up for the American people and take a stronger stance against drugs containing Hydrocodone. Hydrocodone such as that found in Vicodin, is a powerful narcotic painkiller that is highly addictive. As such, it is often taken recreationally in the United States.

The letter comes on the heels of a meeting by the FDA advisory board in which members voted overwhelmingly to re-class drugs with Hydrocodone from Schedule III to Schedule II because of their high potential for misuse. While the FDA normally acts on the advice of its panels, so far the organization has remained silent.

Read more about Policymakers Urge FDA to Do Its Part in Limiting Prescriptions for Vicodin

Provided by Elements Behavioral Health
855-837-1334
Drug Addiction is a Progressive & Deadly disease. Get Help Now!